๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

TCTAP A-035 Aspirin Versus Clopidogrel Following Dual Antiplatelet Therapy on the Era of Drug-eluting Stents

โœ Scribed by Park, Taek Kyu; Song, Young Bin; Yang, Jeong Hoon; Hahn, Joo-Yong; Choi, Seung-Hyuk; Choi, Jin-Ho; Lee, Sang Hoon; Gwon, Hyeon-Cheol

Book ID
122089429
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
379 KB
Volume
63
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Rationale and design of a randomized, do
Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study
โœ Robert A. Byrne; Stefanie Schulz; Julinda Mehilli; Raisuke Iijima; Steffen Massb ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 183 KB
Drug-Eluting Stenting Followed by Cilost
Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients)
โœ Lee, Seung Whan (author);Park, Seong Wook (author);Kim, Young Hak (author);Yun, ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 483 KB
Drug-Eluting Stenting Followed by Cilost
Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients)
โœ Lee, Seung Whan (author);Park, Seong Wook (author);Kim, Young Hak (author);Yun, ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 483 KB